Capital Fund Management (CFM)’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$925K Sell
154,500
-291,400
-65% -$2.19M ﹤0.01% 1711
2025
Q4
$3.2M Sell
445,900
-153,900
-26% -$1.22M 0.01% 1446
2025
Q3
$6.41M Buy
599,800
+43,400
+8% +$426K 0.02% 1090
2025
Q2
$5.39M Buy
556,400
+201,400
+57% +$2.08M 0.01% 1094
2025
Q1
$5.29M Buy
355,000
+48,200
+16% +$741K 0.02% 980
2024
Q4
$4.58M Sell
306,800
-65,200
-18% -$1.06M 0.01% 1122
2024
Q3
$7.12M Sell
372,000
-2,300
-0.6% -$47.7K 0.02% 857
2024
Q2
$7.75M Sell
374,300
-185,400
-33% -$3.68M 0.02% 784
2024
Q1
$10.5M Buy
559,700
+57,700
+11% +$990K 0.03% 709
2023
Q4
$7.24M Buy
502,000
+268,100
+115% +$3.65M 0.02% 933
2023
Q3
$4.06M Buy
233,900
+33,800
+17% +$705K 0.01% 1049
2023
Q2
$4.16M Buy
200,100
+175,200
+704% +$3.81M 0.02% 920
2023
Q1
$586K Buy
+24,900
New +$669K ﹤0.01% 1416

Other funds holding OGN

Capital Fund Management (CFM)'s OGN Position: Q1 2026 in Review

Capital Fund Management (CFM) sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 383,200 shares — an estimated $2.88M sold.

Capital Fund Management (CFM) first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $3.89M in Q2 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Capital Fund Management (CFM) reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 383,200 Organon & Co shares in Q1 2026, an estimated $2.88M.
  • Capital Fund Management (CFM) first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Capital Fund Management (CFM)'s Organon & Co position peaked at $3.89M in Q2 2025.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.